Stockreport

ArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual Meeting

ARQULE  (ARQL) 
Last arqule earnings: 10/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.arqule.com/investor-relations
PDF Conference call and webcast with ArQule management to be held on Monday, December 9, 2019 at 8:15 a.m. ESTArQule management to hold an Investor Event on Monday, December [Read more]